Skip to content

Multicenter Retrospective Study Evaluating ATLANTIS™ Abutment Teeth Connected to Implants

A Retrospective Multicenter Study Evaluating ATLANTIS™ Abutments on Implants From Four Manufacturers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02496091
Enrollment
144
Registered
2015-07-14
Start date
2015-08-31
Completion date
2018-03-30
Last updated
2020-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implants

Brief summary

The study is designed as a retrospective and multi-center study. The study population is US individuals previously restored with titanium and gold-shaded titanium ATLANTIS abutments. The study includes retrospective data collection from the medical records and data collection from one prospective study visit with a clinical examination.The primary objective is to evaluate success. Success is defined as that the study implant and abutment are in situ and no Adverse Device Effects related to the study implant, abutment or adjacent peri-implant tissues are reported during the study.

Interventions

DEVICEATLANTIS Abutment

Sponsors

Dentsply Sirona Implants and Consumables
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Having received one or more ATLANTIS abutments included in one or more permanent prosthetic restoration(s): * during 2010, 2011, 2012 or 2013 * made of titanium or gold-shaded titanium * connected to implants from: BIOMET 3i; Straumann; Nobel Biocare or DENTSPLY Implants (only ASTRA TECH Implant System). * Being at least 18 years at day of enrollment * Having signed and dated the informed consent form

Exclusion criteria

* Unable to come for study visit * Not willing to participate in the study or not able to understand the content of the study. * Involvement in the planning and conduct of the study (applies to both DENTSPLY Implants staff and staff at the study site). * Simultaneous participation in another clinical study that may interfere with the present study

Design outcomes

Primary

MeasureTime frameDescription
Overall Success RateMinium of 2 years and a maximum of 8 years of use.Success defined as study position implant and abutment in situ and no Adverse Event(s) related to implant, abutment or adjacent peri-implant tissues reported during study.

Secondary

MeasureTime frameDescription
Study Position Implant and Abutment SurvivalMinium of 2 years and a maximum of 8 years of use.Survival defined as study position implant and abutment in situ during study. The presence of the study position implant and abutment in the mouth was recorded. The implant and abutment had to be the ones included in the permanent prosthetic restoration when it was delivered / installed. Each study position was categorized as survived (No/Yes). It was categorized as survived=Yes when both had been in situ during study. It was categorized as survived=No when either the implant or abutment had been lost during study.
Presence of PlaqueMinium of 2 years and a maximum of 8 years of use.Presence of plaque was evaluated at four surfaces around each study position (mesial, facial, distal and lingual). Plaque was recorded as presence or absence of plaque by visual inspection.
Evaluation of the Periimplant Mucosa Condition - By Assessment of PPDMinium of 2 years and a maximum of 8 years of use.PPD was evaluated at four surfaces around each study position (mesial, facial, distal and lingual), using a periodontal probe. PPD was measured as the distance from the mucosal margin to the bottom of the probeable pocket in whole millimetre. PPD mean values per study positon were calculated.
Evaluation of the Periimplant Mucosa Condition - By Assessment of BoPMinium of 2 years and a maximum of 8 years of use.Condition of the periimplant mucosa by assessment of Bleeding on Probing (BoP). BoP was evaluated at four surfaces around each study position (mesial, facial, distal and lingual), using a periodontal probe. BoP was recorded as presence or absence of bleeding when probing to the bottom of the pocket. Presented as % of positions that show presence of bleeding on probing at time of the follow-up visit.
Marginal Bone Level ChangeMinium of 2 years and a maximum of 8 years of use.Marginal bone level (MBL) determined from radiographs and expressed as the distance from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant. Marginal bone level expressed in millimeters at the study follow-up visit was compared to values obtained at delivery of permanent restoration i.e. loading (baseline), or within the first 12 months after loading.

Countries

United States

Participant flow

Participants by arm

ArmCount
ATLANTIS Abutment
ATLANTIS Abutment, component used in permanent dental prosthetic restorations. Used for connecting the dental implant with the dental restoration.
142
ATLANTIS Abutment
ATLANTIS Abutment, component used in permanent dental prosthetic restorations. Used for connecting the dental implant with the dental restoration.
259
Total401

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyEligibility criteria not fulfilled2

Baseline characteristics

CharacteristicATLANTIS Abutment
Age, Continuous63.9 years
STANDARD_DEVIATION 11.85
Region of Enrollment
United States
142 Participants
Sex: Female, Male
Female
81 Participants
Sex: Female, Male
Male
61 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 142
other
Total, other adverse events
0 / 142
serious
Total, serious adverse events
0 / 142

Outcome results

Primary

Overall Success Rate

Success defined as study position implant and abutment in situ and no Adverse Event(s) related to implant, abutment or adjacent peri-implant tissues reported during study.

Time frame: Minium of 2 years and a maximum of 8 years of use.

Population: 144 subjects (263 implant positions) were signed informed consent and were enrolled in the study. 2 subject (4 implant positions) were excluded due to eligibility criteria not fulfilled.~As a result, a total of 142 subjects (259 implant positions) are included in the analysis.

ArmMeasureValue (COUNT_OF_UNITS)
ATLANTIS AbutmentOverall Success Rate240 Abutments
Comparison: Only descriptive statistics The implant success rate is analyzed on an implant level (i.e. percent of successful implants) as well as subject level (i.e. percentage of subjects with no unsuccessful implants). This proportion is presented together with a 95% confidence interval (using the exact Binomial approach) and an average follow-up time.95% CI: [88.8, 95.5]
Secondary

Evaluation of the Periimplant Mucosa Condition - By Assessment of BoP

Condition of the periimplant mucosa by assessment of Bleeding on Probing (BoP). BoP was evaluated at four surfaces around each study position (mesial, facial, distal and lingual), using a periodontal probe. BoP was recorded as presence or absence of bleeding when probing to the bottom of the pocket. Presented as % of positions that show presence of bleeding on probing at time of the follow-up visit.

Time frame: Minium of 2 years and a maximum of 8 years of use.

Population: 144 subjects (263 implant positions) were enrolled in the study. 2 subject (4 implant positions) were excluded due to eligibility criteria not fulfilled giving a per protocol population of 142 subjects (259 positions) .~PPD assessment was not completed for 4 positions. As a result, a total of 255 positions are included in the PPD analysis.

ArmMeasureValue (COUNT_OF_UNITS)
ATLANTIS AbutmentEvaluation of the Periimplant Mucosa Condition - By Assessment of BoP124 Positions
Secondary

Evaluation of the Periimplant Mucosa Condition - By Assessment of PPD

PPD was evaluated at four surfaces around each study position (mesial, facial, distal and lingual), using a periodontal probe. PPD was measured as the distance from the mucosal margin to the bottom of the probeable pocket in whole millimetre. PPD mean values per study positon were calculated.

Time frame: Minium of 2 years and a maximum of 8 years of use.

Population: 144 subjects (263 implant positions) were enrolled in the study. 2 subject (4 implant positions) were excluded due to eligibility criteria not fulfilled giving a per protocol population of 142 subjects (259 positions) .~PPD assessment was not completed for 4 positions. As a result, a total of 255 positions are included in the PPD analysis.

ArmMeasureValue (MEAN)Dispersion
ATLANTIS AbutmentEvaluation of the Periimplant Mucosa Condition - By Assessment of PPD3.11 MillimeterStandard Deviation 1
Secondary

Marginal Bone Level Change

Marginal bone level (MBL) determined from radiographs and expressed as the distance from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant. Marginal bone level expressed in millimeters at the study follow-up visit was compared to values obtained at delivery of permanent restoration i.e. loading (baseline), or within the first 12 months after loading.

Time frame: Minium of 2 years and a maximum of 8 years of use.

Population: Per protocol population is 142 subjects (259 positions) . For 39 subjects (94 positions) there were no baseline radiographs available for analysis. As a result, a total of 165 positions are included in the analysis of MBL change.

ArmMeasureValue (MEAN)Dispersion
ATLANTIS AbutmentMarginal Bone Level Change-0.30 MillimeterStandard Deviation 0.93
Secondary

Presence of Plaque

Presence of plaque was evaluated at four surfaces around each study position (mesial, facial, distal and lingual). Plaque was recorded as presence or absence of plaque by visual inspection.

Time frame: Minium of 2 years and a maximum of 8 years of use.

Population: 144 subjects (263 implant positions) were enrolled in the study. 2 subject (4 implant positions) were excluded due to eligibility criteria not fulfilled giving a per protocol population of 142 subjects (259 positions) .~Plaque assessment was not completed for 4 positions. As a result, a total of 255 positions are included in the Plaque analysis.

ArmMeasureValue (COUNT_OF_UNITS)
ATLANTIS AbutmentPresence of Plaque96 Positions
Secondary

Study Position Implant and Abutment Survival

Survival defined as study position implant and abutment in situ during study. The presence of the study position implant and abutment in the mouth was recorded. The implant and abutment had to be the ones included in the permanent prosthetic restoration when it was delivered / installed. Each study position was categorized as survived (No/Yes). It was categorized as survived=Yes when both had been in situ during study. It was categorized as survived=No when either the implant or abutment had been lost during study.

Time frame: Minium of 2 years and a maximum of 8 years of use.

Population: 144 subjects (263 implant positions) were enrolled in the study. 2 subject (4 implant positions) were excluded due to eligibility criteria not fulfilled giving a per protocol population of 142 subjects (259 positions).

ArmMeasureValue (COUNT_OF_UNITS)
ATLANTIS AbutmentStudy Position Implant and Abutment Survival256 Abutments

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026